Showing results (201-210 of 228) with videos related to
Sort By:
Pageof 23
Cancer Research|December 3, 1999
Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladderS I Mohammed, D W Knapp, D G Bostwick, et al.Pediatric Pulmonology|December 10, 1999
Mechanisms of nocturnal oxyhemoglobin desaturation in children and adolescents with sickle cell diseaseJ P Needleman, M E Franco, L Varlotta, et al.Lipids|January 25, 2002
Lipid remodeling in mouse liver and plasma resulting from delta6 fatty acid desaturase inhibitionK L Duffin, M G Obukowicz, W J Salsgiver, et al.The American Journal of Physiology|July 1, 1985
Atriopeptins: correlation between renal vasodilation and natriuresisK Wakitani, B R Cole, D M Geller, et al.Science (New York, N.Y.)|July 26, 1985
Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptideD Schwartz, D M Geller, P T Manning, et al.Circulation Research|December 1, 1990
Brain natriuretic peptide-like immunoreactive innervation of the cardiovascular and cerebrovascular systems in the ratC B Saper, M R Kibbe, K M Hurley, et al.International Journal of Cardiology|March 1, 1992
Localization of brain and atrial natriuretic peptide in human and porcine heartA Pucci, J Wharton, E Arbustini, et al.Cancer Research|May 27, 1999
Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammationP Michaluart, J L Masferrer, A M Carothers, et al.Molecular Pharmacology|December 1, 1986
Proteolytic processing of atriopeptin prohormoneM L Michener, J K Gierse, R Seetharam, et al.Science (New York, N.Y.)|July 1, 1983
Bioactive cardiac substances: potent vasorelaxant activity in mammalian atriaM G Currie, D M Geller, B R Cole, et al.Pageof 23